SMOT ETF: What Is It? A Complete Guide to Returns, Expense Ratio, Holdings, and Alternative ETFs
The VanEck Morningstar SMID Moat ETF (SMOT) is a passive product that invests in undervalued U.S. small and mid-cap companies with economic moats. Its moat and undervaluation screening structure, along with how its selectivity and concentration differ from products related to IWR, VO, and MDY, are the key selection criteria.
What Is the VanEck Morningstar SMID Moat ETF?
This is a passive ETF that selects and invests in undervalued stocks, relative to fair value, from among U.S. small and mid-cap companies that Morningstar has judged to have economic moats. It screens stocks by weighing competitive advantage and valuation together.
It suits investors who want to invest in undervalued small and mid-cap stocks with competitive advantages and are willing to accept small and mid-cap volatility.
It is an ETF managed by VanEck using a passive (index-tracking) approach.
How Does the VanEck Morningstar SMID Moat ETF Invest?
| Item | Details |
|---|---|
| Investment target | U.S. small and mid-cap moat companies |
| Management style | Passive (moat and undervaluation screening) |
| Selection criteria | Economic moat plus undervaluation |
| Dividend frequency | Annual dividend |
| Expense ratio | 0.49% |
It tracks an index that selects and holds undervalued stocks, relative to fair value, from among U.S. small and mid-cap companies that Morningstar has judged to have economic moats. By weighing competitive advantage and valuation together, it follows a rules-based structure that concentrates on small and mid-cap companies that have moats yet remain undervalued.
- Evaluates economic moat and undervaluation together
- Concentrates on small and mid-cap moat companies
VanEck Morningstar SMID Moat ETF Size and Costs (AUM and Management Fee)
Assets under management (AUM) stand at $321.0M, and the expense ratio is an annual 0.49%.
Compared with a plain mid-cap index ETF or a large-cap moat ETF, its concentration on small and mid-cap moat and undervaluation is the main point of comparison.
VanEck Morningstar SMID Moat ETF Performance and Trends
Small and mid-cap moat stocks react sensitively to the economic cycle, interest rates, and market risk appetite, and moat and undervaluation strategies tend to show relative strength when value stocks are in favor and relative weakness when growth stocks lead. Given the nature of small and mid-cap stocks, volatility tends to be higher than for large caps.
Fund flows into small and mid-cap moat stocks diverge depending on the economic outlook, risk appetite, and style rotation, and money sometimes shifts toward related product groups when interest in moat and value investing rises. It is also worth watching how performance varies with the economy and style rotation.
VanEck Morningstar SMID Moat ETF Pros and Cons
Its strengths are moat and undervaluation screening and small and mid-cap exposure, while small and mid-cap volatility, weakness in growth-led markets, and tracking differences are considerations.
💪 Key Strengths
⚠️ Points to Watch
VanEck Morningstar SMID Moat ETF Alternative ETFs and Related Products
For mid-cap exposure without moat screening, direct substitutes include IWR and VO, and for other mid-cap exposure, products such as MDY are also worth comparing. This ETF is differentiated by its narrower exposure to undervalued small and mid-cap stocks with economic moats, and unlike large-cap moat products, it concentrates on the small and mid-cap segment.
| Ticker | Name | Price | Change | AUM | Total Expense Ratio | Dividend Yield | 1Y |
|---|---|---|---|---|---|---|---|
| VanEck Morningstar Wide Moat ETF | $111.97 | -0.1% | $11.8B | 0.46% | 1.25% | +9.0% | |
| Pacer Trendpilot US Large Cap ETF | $59.77 | +0.7% | $3.3B | 0.60% | 0.99% | +7.4% | |
| Innovator Defined Wealth Shield ETF | $35.04 | +0.2% | $3.2B | 0.69% | - | +6.3% | |
| Aptus Collared Investment Opportunity ETF | $46.90 | +0.6% | $2.4B | 0.79% | 0.39% | +6.6% | |
| Invesco BuyBack Achievers ETF | $150.50 | +0.2% | $1.7B | 0.63% | 0.64% | +12.5% |
| Ticker | Name | Weight | Price | Change | Market Cap | P/E | Dividend Yield |
|---|---|---|---|---|---|---|---|
| Acuity Inc | 0.02% | $318.72 | +0.0% | $9.5B | 18.7 | 0.26% | |
| DVN | Devon Energy Corp | 0.02% | $51.64 | +0.5% | $56.8B | 12.2 | 2.23% |
| Bio-Techne Corp | 0.02% | $72.69 | +0.2% | $11.4B | 62.8 | 0.44% | |
| Akamai Technologies Inc | 0.02% | $98.50 | +5.3% | $14.2B | 35.5 | - | |
| SLB | SLB Ltd | 0.02% | $53.08 | +0.0% | $78.8B | 25.9 | 2.22% |
| Albemarle Corp | 0.02% | $93.42 | -0.3% | $11.0B | - | 1.73% | |
| Corteva Inc | 0.02% | $11.95 | -4.0% | $8.0B | 7.9 | 0.75% | |
| Masco Corp | 0.02% | $75.51 | -0.7% | $14.9B | 17.4 | 1.69% | |
| RPRX | Royalty Pharma plc | 0.02% | $64.76 | +1.4% | $28.8B | 34.5 | 1.58% |
| BIIB | Biogen Inc | 0.01% | $252.26 | +0.6% | $37.3B | 44.7 | - |
VanEck Morningstar SMID Moat ETF Investor Checkpoints
Here are the points to check before investing in SMOT. Moat and undervaluation screening and small and mid-cap exposure are appealing, but small and mid-cap volatility, weakness in growth-led markets, and tracking differences need to be confirmed in advance. It is also a good idea to compare it with plain mid-cap and large-cap moat products.
| Checkpoint | What to check | Current status |
|---|---|---|
| 🏰 Moat screening | Review the economic moat and undervaluation criteria | Moat and undervaluation |
| 🏢 Small and mid-cap exposure | Review the makeup of small and mid-cap moat companies | Small and mid-cap focus |
| ⚡ Volatility | Review small and mid-cap volatility | On the high side |
| 🔄 Style rotation | Review value and growth phases | Needs checking |
Relative weakness in growth-led markets, small and mid-cap volatility, and tracking differences are the main variables for long-term performance, and moat and undervaluation screening can make its composition differ from market-cap-weighted small and mid-cap indexes. Given the nature of small and mid-cap stocks, declines can be steep during market crashes.
It is a suitable candidate for investors who want to invest in undervalued small and mid-cap stocks with competitive advantages. If plain mid-cap exposure is the priority, compare products such as IWR and VO, and if you want small and mid-cap moat and undervaluation screening, it is advisable to weigh this product alongside them.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.
This article reflects information as of June 10, 2026.